
Korea has been investing 3.47% of GDP in R&D in year of 2007, which marked ranking 3 in the world in the amount of investment. Technology balance of payments deficit, however, rose to 2.93 billion dollar in year of 2007 in spite of such R&D investment. Now, it is urgently needed to invest strategically in R&D considering intellectual property.
In this presentation, the application of the method of enforcing IP strategy to the field of bio-industry is introduced.